Sunflower Pharmaceutical Group (002737.SZ) plans to invest 10 million yuan in setting up a subsidiary in Hubei.

date
17:59 31/03/2026
avatar
GMT Eight
Aibiao Pharmaceutical Co., Ltd. (002737.SZ) announced that the company has decided to use their own funds of 10 million yuan to invest in the establishment of a wholly-owned subsidiary, Aibiao Pharmaceutical Group (Hubei) Pharmaceutical Co., Ltd. (provisional).
Sunflower Pharmaceutical Group (002737.SZ) announced that the company has decided to invest 10 million yuan of its own funds to establish a wholly-owned subsidiary, Sunflower Pharmaceutical Group (Hubei) Medicine Co., Ltd. (pending). The establishment of the wholly-owned subsidiary Hubei Medicine Company is part of the company's strategic plan to "refine the group, solidify the subsidiaries," promote independent accounting and operations of various marketing system models and business sectors, strengthen precise resource allocation, unleash the organization's internal dynamics, and enhance overall operational efficiency of the company.